Humanized docking system for assembly of targeting drug delivery complexes

Journal of Controlled Release

Volumn 89, Issue 3, 2003, Pages 499-511

  Backer, Marina V ^a   Gaynutdinov, Timur I ^a   Gorshkova, Inna I ^b   Crouch, Robert J ^b   Hu, Tao ^a   Aloise, Renee ^a   Arab, Mohamed ^a   Przekop, Kristen ^a   Backer, Joseph M ^a  

^a SIBTECH INC   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

Assembled targeting complexes; Gene therapy; Human RNase; Targeted delivery; Vascular endothelial growth factor

Indexed keywords

AMINO ACIDS; DNA; ENZYME KINETICS; ENZYMES; HUMAN ENGINEERING; LIGHT SCATTERING; SURFACE PLASMON RESONANCE;

BIOLOGICAL RECEPTORS; COMPLEX COMPOUNDS;

DRUG INTERACTIONS;

AMINO ACID; PANCREAS ENZYME; RECEPTOR; RIBONUCLEASE; VASCULOTROPIN;

AMINO TERMINAL SEQUENCE; ARTICLE; COVALENT BOND; DRUG DELIVERY SYSTEM; DRUG TARGETING; DYNAMICS; ENZYME ACTIVITY; GENE TARGETING; HUMAN; HUMAN CELL; LIGHT SCATTERING; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN ASSEMBLY; PROTEIN ENGINEERING; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN INTERACTION; PROTEIN TARGETING; SURFACE PLASMON RESONANCE;

EID: 0038402541     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(03)00150-0     Document Type: Article

References (25)

1. Dubowchik G.M., Walker M.A. Receptor-mediated and enzyme-dependent targeting of cytotoxic anticancer drugs. Pharmacol. Ther. 83:1999;67-123.
2. Backer M.V., Aloise R., Przekop K., Stoletov K., Backer J.M. Molecular vehicles for targeted drug delivery. Bioconj. Chem. 13:2002;462-467.
3. Gaidamakova E.K., Backer M.V., Backer J.M. Molecular vehicle for target-mediated delivery of therapeutic and diagnostics. J. Controlled Release. 74:2001;341-347.
4. Pous J., Mallorquí-Fernández G., Peracaula R., Terzyan S.S., Futami J., Tada H., Yamada H., Seno M., de Llorens R., Gomis-Rüth F.X., Coll M. Three-dimensional structure of human RNase 1 delta N7 at 1.9 A resolution. Acta Crystallogr. D. Biol. Crystallogr. 57:2001;498-505.
5. D'Alessio G., Riordan J.F. Ribonucleases: Structures and Functions. 1997;Academic Press, New York.
6. Connelly P.R., Varadarajan R., Sturtevant J.M., Richards F.M. Thermodynamics of protein-peptide interactions in the ribonuclease S system studied by titration calorimetry. Biochemistry. 29:1990;6108-6114.
7. Dubel S. Reconstitution of human pancreatic RNase from two separate fragments fused to different single chain antibody fragments: on the way to binary immunotoxins. Tumor Target. 4:1999;37-46.
8. Backer M.V., Gaynutdinov T.I., Aloise R., Przekop K., Backer J.M. Engineering S-protein fragments of bovine ribonuclease A for targeted drug delivery. Prot. Exp. Purif. 26:2002;455-461.
9. Backer M.V., Backer J.M. Functionally active VEGF fusion proteins. Prot. Exp. Purif. 23:2001;1-7.
10. Kuzmic P. Program DYNAFIT for the analysis of enzyme kinetic data: Application to HIV proteinase. Anal. Biochem. 237:1996;260-273.
11. Kunitz M. A spectrophotometric method for the measurement of ribonuclease activity. J. Biol. Chem. 164:1946;563-568.
12. Libonati M., Floridi A. Breakdown of double-stranded RNA by bull semen ribonuclease. Eur. J. Biochem. 8:1969;81-87.
13. Gorshkova I.I., Rausch J.W., Le Grice S.F., Crouch R.J. HIV-1 reverse transcriptase interaction with model RNA-DNA duplexes. Anal. Biochem. 291:2001;198-206.
14. Morton T.A., Myzska D.G. Methods in Enzymology, Kinetic Analysis of Macromolecular Interactions Using Surface Plasmon Resonance Biosensors, Part B. 1998;Academic Press, New York. pp. 268-294.
15. McCormic M., Mierendorf R. S-tag: a multipurpose fusion peptide for recombinant proteins, inNovations. Novagen Bull. 13:2001;4-6.
16. Richards F.M., Vithayathil P.J. The preparation of subtilisin-modified ribonuclease and the separation of the peptide and protein components. J. Biol. Chem. 234:1959;1459-1465.
17. Boussif O., Lezoualch F., Zanta M.-A., Mergny M.D., Scherman D., Demeneix B., Behr J.-P. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo. Proc. Natl. Acad. Sci. USA. 92:1995;7297-7301.
18. Backer M.V., Backer J.M. Targeting endothelial cells overexpressing VEGFR-2: selective toxicity of Shiga-like toxin-VEGF fusion proteins. Bioconjugate Chem. 12:2001;1066-1073.
19. Brown L.F., Berse B., Jackman R.W., Tognazzi K., Manseau E.J., Dvorak H.F., Senger D.R. Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas. Am. J. Pathol. 143:1993;1255-1262.
20. Plate K.H., Breier G., Millauer B., Ullrich A., Risau W. Up-regulation of vascular endothelial growth factor and its cognate receptors in a rat glioma model of tumor angiogenesis. Cancer Res. 53:1993;5822-5827.
21. Brown L.F., Berse B., Jackman R.W., Tognazzi K., Guidi A.J., Dvorak H.F., Enger D.R., Connolly J.L., Schnitt S.J. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer. Hum. Pathol. 26:1995;86-91.
22. Tobias J.W., Shrader T.E., Rocap G., Varchavsky A. The N-end rule in bacteria. Science. 254:1991;1374-1377.
23. Goldberg J.M., Baldwin R.L. A specific transition state for S-peptide combining with folded S-protein and then refolding. Proc. Natl. Acad. Sci. USA. 96:1999;2019-2024.
24. Raines R.T. Ribonuclease A. Chem. Rev. 98:1998;1045-1065.
25. Futami J., Seno M., Ueda M., Tada H., Yamada H. Inhibition of cell growth by a fused protein of human ribonuclease 1 and human basic fibroblast growth factor. Prot. Eng. 12:1999;1013-1019.